PAK5 is auto-activated by a central domain that promotes kinase oligomerization.


PAKs (p21 activated kinases) are an important class of Rho effectors. These contain a Cdc42-Rac1 interaction and binding (CRIB) domain and a flanking auto-inhibitory domain (AID) which binds the C-terminal catalytic domain. The group II kinases PAK4 and PAK5 are considered significant therapeutic targets in cancer. Among human cancer cell lines we tested… (More)
DOI: 10.1042/BCJ20160132

10 Figures and Tables


  • Presentations referencing similar topics